ALTITUDE LIFE SCIENCE VENTURES
Philosophy is to focus on life science markets with strong demand and growth potential, and then back the highest-quality entrepreneurs in those markets to build defensible, strong, and long-term businesses. build portfolio among attractive life science sectors in a manner that balances risk while maximizing potential synergies and ultimate returns. Our focus is on opportunities in biotechnology, medical devices, and diagnostics, but we are continually responsive to the best areas for investi... ng in order to adapt to changing market conditions. Invest in companies that: * are pursuing substantial and growing market opportunities * possess a unique and proprietary technology, with a clear competitive advantage * are early-stage opportunities * have or will attract strong management * have a strong investment syndicate * offer a defined path to liquidity
ALTITUDE LIFE SCIENCE VENTURES
Industry:
Biotechnology Finance Life Science Venture Capital
Founded:
2006-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Google GStatic Google Static Content
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Wasabi Ventures
Wasabi Ventures has planned, implemented, and maintained solutions for many early-stage startups.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-19 | Tessera Therapeutics | Altitude Life Science Ventures investment in Series C - Tessera Therapeutics | 300 M USD |
| 2022-04-11 | Ansa Biotechnologies | Altitude Life Science Ventures investment in Series A - Ansa Biotechnologies | 68 M USD |
| 2021-11-18 | Generate Biomedicines | Altitude Life Science Ventures investment in Series B - Generate Biomedicines | 370 M USD |
| 2021-10-26 | Mozart Therapeutics | Altitude Life Science Ventures investment in Series A - Mozart Therapeutics | 55 M USD |
| 2021-10-07 | Neumora Therapeutics | Altitude Life Science Ventures investment in Series A - Neumora Therapeutics | 400 M USD |
| 2021-08-26 | Effector Therapeutics | Altitude Life Science Ventures investment in Post-IPO Equity - Effector Therapeutics | 60 M USD |
| 2021-07-28 | Ring Therapeutics | Altitude Life Science Ventures investment in Series B - Ring Therapeutics | 117 M USD |
| 2021-01-12 | Tessera Therapeutics | Altitude Life Science Ventures investment in Series B - Tessera Therapeutics | 230 M USD |
| 2021-01-08 | Dice Therapeutics | Altitude Life Science Ventures investment in Series C - Dice Therapeutics | 80 M USD |
| 2020-06-23 | Sana Biotechnology | Altitude Life Science Ventures investment in Series A - Sana Biotechnology | 700 M USD |